ProgMod: An Analytical Model for Prognosis Prediction of AML Patients Using Survival Regression and Gene Expression Levels

An accurate prediction of prognosis to the patient diagnosed with Acute Myeloid Leukemia (AML) is an enormously difficult task. Several solutions have been proposed for prognosis prediction however there is a scope to improve current solutions. In this paper we aim at developing a solution that estimates the survival time that is the Prognosis of patients diagnosed with AML. To that end, we used a machine learning model that is built on an algorithm called Survival Regression. The model consumes as input the Expression Levels of a small number of the genes of the patient.

[1]  W. Evans,et al.  A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study. , 2009, The Lancet. Oncology.

[2]  Ali Nehme,et al.  Atlas of tissue renin-angiotensin-aldosterone system in human: A transcriptomic meta-analysis , 2015, Scientific Reports.

[3]  Beilun Wang,et al.  Kernelized Information-Theoretic Metric Learning for Cancer Diagnosis Using High-Dimensional Molecular Profiling Data , 2016, ACM Trans. Knowl. Discov. Data.

[4]  H. Kantarjian,et al.  Acute myeloid leukemia , 2018, Methods in Molecular Biology.

[5]  J. Mesirov,et al.  Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.

[6]  Keith Wheatley,et al.  Prognostic factor analysis of the survival of elderly patients with AML in the MRC AML11 and LRF AML14 trials , 2009, British journal of haematology.

[7]  Carmine Zoccali,et al.  The analysis of survival data in nephrology: basic concepts and methods of Cox regression. , 2008, Kidney international.

[8]  Sara Tarek,et al.  Gene expression based cancer classification , 2017 .

[9]  Robert Koprowski,et al.  Machine learning, medical diagnosis, and biomedical engineering research - commentary , 2014, BioMedical Engineering OnLine.

[10]  Todd R. Golub,et al.  MicroRNA Expression Signatures Accurately Discriminate Acute Lymphoblastic Leukemia from Acute Myeloid Leukemia. , 2007 .

[11]  Yuri Fedoriw,et al.  Genetic tests to evaluate prognosis and predict therapeutic response in acute myeloid leukemia. , 2010, The Journal of molecular diagnostics : JMD.

[12]  N. Hamdi,et al.  Selecting significant marker genes from microarray data by filter approach for cancer diagnosis , 2018 .